139 results
8-K
EX-10.1
LEXX
Lexaria Bioscience Corp
16 Feb 24
Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:30pm
pursuant to the Company’s equity incentive plan, the Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any
424B5
gnat2c7 4ma6d
16 Feb 24
Prospectus supplement for primary offering
6:01am
8-K
EX-99.1
qoo64e
24 Jan 24
Regulation FD Disclosure
2:12pm
POS AM
u9lwuq 2k8
24 Jan 24
Prospectus update (post-effective amendment)
1:33pm
S-8
hxbbefkl4
18 Jan 24
Registration of securities for employees
2:38pm
S-8
ejcqct s1lmzcc6j
18 Jan 24
Registration of securities for employees
2:38pm
S-8
EX-4.1
x3x6pmj7q mip
18 Jan 24
Registration of securities for employees
2:38pm
8-K
EX-10.1
6tjauw
3 Oct 23
Entry into a Material Definitive Agreement
4:05pm
424B5
xy8z32rgsggxdq7t9zyo
2 Oct 23
Prospectus supplement for primary offering
4:06pm
424B4
s4hj paxv
10 May 23
Prospectus supplement with pricing info
4:30pm
8-K
bfap qhm1
10 May 23
Submission of Matters to a Vote of Security Holders
11:12am